See All Slides -

Slides

Presentation TCT 2012

CAS Decision Making in Difficult Aortic Arches

Presenter: D. Christopher Metzger

October 22, 2012

Presentation TCT 2012

Debate II. Is Aggressive Endovascular Treatment of Pulmonary Embolism Justified? Pro!

Presenter: Gary Ansel

October 22, 2012

Presentation TCT 2012

How to Establish a Viable Clinical Research Program in Your Hospital: Essential First Steps and Standards

Presenter: Timothy Henry

October 22, 2012

Presentation TCT 2012

What Is Optimal Medical Management for Carotid Disease, and What Residual Risk Remains Without Revascularization?

Presenter: Michael Jaff

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

Presenter: Lawrence Garcia

October 22, 2012

Presentation

Are There Gender Differences in the Management of STEMI?Are There Gender Differences in the Management of STEMI?

Presenter: Guillaume Leurent

October 22, 2012

Presentation TCT 2012

Patient Selection

Presenter: Krishna Rocha-Singh

October 22, 2012

Presentation TCT 2012

Prospective, Multicenter Evaluation of the 18F Direct Flow Transcatheter Aortic Valve: CE Mark study

Presenter: Joachim Schofer

October 22, 2012

Presentation TCT 2012

Approach to the Case with Limited/No Retrograde Options

Presenter: Carlo Di Mario

October 22, 2012

Presentation TCT 2012

Endogenous Stem Cell Repair in Response to Acute Injury

Presenter: Feng Dong

October 22, 2012

Advertisement

Slides

CAS Decision Making in Difficult Aortic Arches

Debate II. Is Aggressive Endovascular Treatment of Pulmonary Embolism Justified? Pro!

How to Establish a Viable Clinical Research Program in Your Hospital: Essential First Steps and Standards

What Is Optimal Medical Management for Carotid Disease, and What Residual Risk Remains Without Revascularization?

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

Are There Gender Differences in the Management of STEMI?Are There Gender Differences in the Management of STEMI?

Patient Selection

Prospective, Multicenter Evaluation of the 18F Direct Flow Transcatheter Aortic Valve: CE Mark study

Approach to the Case with Limited/No Retrograde Options

Endogenous Stem Cell Repair in Response to Acute Injury

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content